Innovation

Functionally Inhibitory JAML Monoclonal Antibodies

Emory University
posted on 01/18/2012

Applications

  • Flow Cytometry
  • Immunoprecipitation
  • Functional Assays
Specificity

Human

Subtype

Mouse Monoclonal

Immunogen

Recombinant human JAML

Technical Summary

Junctional adhesion molecules (JAMs) are a family of glycoproteins important in the control of vascular permeability and leukocyte transmigration across endothelial-cell surfaces. JAMs play a vital role in epithelial inflammation by regulating leukocyte transmigration and barrier function. Emory researchers have created several mAbs that bind differently to JAML with partial to complete inhibition of JAML ligands.

]]>


Innovation Details
 

File Number: 11005 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Panya Taysavang at Emory University for more information.

Request more info via email request more info
People

Principal Investigator:

Charles Parkos Charles Parkos

Innovations (7)

Publications (6)



Co-Investigators:

Dominique Weber Dominique Weber

Innovations (1)

Case Manager:

Panya Taysavang Panya Taysavang

Innovations (74)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

8,771 members 16,654 innovations 159 organizations

Browse

David Kolb, CEO and chairman of the board, Emunamedica LLC.

"We found tremendous value and benefit in using the iBridge Network..."  read more...